Logo image of ATRC

ATRICURE INC (ATRC) Stock Fundamental Analysis

USA - NASDAQ:ATRC - US04963C2098 - Common Stock

37.16 USD
-0.08 (-0.21%)
Last: 10/17/2025, 8:00:01 PM
36.72 USD
-0.44 (-1.18%)
After Hours: 10/17/2025, 8:00:01 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ATRC. ATRC was compared to 191 industry peers in the Health Care Equipment & Supplies industry. While ATRC seems to be doing ok healthwise, there are quite some concerns on its profitability. ATRC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ATRC has reported negative net income.
ATRC had a positive operating cash flow in the past year.
ATRC had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ATRC reported negative operating cash flow in multiple years.
ATRC Yearly Net Income VS EBIT VS OCF VS FCFATRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

ATRC has a Return On Assets of -5.97%. This is in the better half of the industry: ATRC outperforms 65.97% of its industry peers.
ATRC's Return On Equity of -7.83% is fine compared to the rest of the industry. ATRC outperforms 67.02% of its industry peers.
Industry RankSector Rank
ROA -5.97%
ROE -7.83%
ROIC N/A
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ATRC Yearly ROA, ROE, ROICATRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

ATRC has a better Gross Margin (74.71%) than 86.91% of its industry peers.
In the last couple of years the Gross Margin of ATRC has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ATRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
ATRC Yearly Profit, Operating, Gross MarginsATRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

ATRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATRC has been increased compared to 1 year ago.
The number of shares outstanding for ATRC has been increased compared to 5 years ago.
ATRC has a worse debt/assets ratio than last year.
ATRC Yearly Shares OutstandingATRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ATRC Yearly Total Debt VS Total AssetsATRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ATRC has an Altman-Z score of 7.77. This indicates that ATRC is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ATRC (7.77) is better than 88.48% of its industry peers.
ATRC has a debt to FCF ratio of 8.42. This is a slightly negative value and a sign of low solvency as ATRC would need 8.42 years to pay back of all of its debts.
ATRC's Debt to FCF ratio of 8.42 is fine compared to the rest of the industry. ATRC outperforms 74.87% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that ATRC is not too dependend on debt financing.
ATRC has a Debt to Equity ratio (0.15) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 8.42
Altman-Z 7.77
ROIC/WACCN/A
WACC8.59%
ATRC Yearly LT Debt VS Equity VS FCFATRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

ATRC has a Current Ratio of 3.94. This indicates that ATRC is financially healthy and has no problem in meeting its short term obligations.
ATRC's Current ratio of 3.94 is fine compared to the rest of the industry. ATRC outperforms 69.11% of its industry peers.
ATRC has a Quick Ratio of 2.83. This indicates that ATRC is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.83, ATRC is doing good in the industry, outperforming 67.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.94
Quick Ratio 2.83
ATRC Yearly Current Assets VS Current LiabilitesATRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.33% over the past year.
The Revenue has grown by 16.28% in the past year. This is quite good.
Measured over the past years, ATRC shows a quite strong growth in Revenue. The Revenue has been growing by 15.05% on average per year.
EPS 1Y (TTM)52.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.24%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%17.09%

3.2 Future

Based on estimates for the next years, ATRC will show a very strong growth in Earnings Per Share. The EPS will grow by 23.01% on average per year.
The Revenue is expected to grow by 13.30% on average over the next years. This is quite good.
EPS Next Y28.98%
EPS Next 2Y29.76%
EPS Next 3Y28%
EPS Next 5Y23.01%
Revenue Next Year14.51%
Revenue Next 2Y13.43%
Revenue Next 3Y13.35%
Revenue Next 5Y13.3%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ATRC Yearly Revenue VS EstimatesATRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ATRC Yearly EPS VS EstimatesATRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATRC. In the last year negative earnings were reported.
Also next year ATRC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATRC Price Earnings VS Forward Price EarningsATRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ATRC indicates a somewhat cheap valuation: ATRC is cheaper than 68.06% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 222.86
EV/EBITDA N/A
ATRC Per share dataATRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as ATRC's earnings are expected to grow with 28.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.76%
EPS Next 3Y28%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ATRC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATRICURE INC

NASDAQ:ATRC (10/17/2025, 8:00:01 PM)

After market: 36.72 -0.44 (-1.18%)

37.16

-0.08 (-0.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners100.55%
Inst Owner Change-0.1%
Ins Owners3.41%
Ins Owner Change1.33%
Market Cap1.85B
Analysts85.33
Price Target52.02 (39.99%)
Short Float %4.29%
Short Ratio3.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.19%
Min EPS beat(2)40.06%
Max EPS beat(2)88.31%
EPS beat(4)4
Avg EPS beat(4)52.14%
Min EPS beat(4)14.39%
Max EPS beat(4)88.31%
EPS beat(8)7
Avg EPS beat(8)29.57%
EPS beat(12)10
Avg EPS beat(12)31.55%
EPS beat(16)11
Avg EPS beat(16)69.13%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-1.4%
Max Revenue beat(2)2.54%
Revenue beat(4)2
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-1.4%
Max Revenue beat(4)2.54%
Revenue beat(8)3
Avg Revenue beat(8)0.09%
Revenue beat(12)6
Avg Revenue beat(12)0.47%
Revenue beat(16)9
Avg Revenue beat(16)0.75%
PT rev (1m)0%
PT rev (3m)1.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20.38%
EPS NY rev (1m)-10.44%
EPS NY rev (3m)8.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.69
P/FCF 222.86
P/OCF 50.69
P/B 3.98
P/tB 10.41
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)0.17
FCFY0.45%
OCF(TTM)0.73
OCFY1.97%
SpS10.06
BVpS9.35
TBVpS3.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.97%
ROE -7.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.71%
FCFM 1.66%
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 8.42
Debt/EBITDA N/A
Cap/Depr 140.66%
Cap/Sales 5.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.94
Quick Ratio 2.83
Altman-Z 7.77
F-Score4
WACC8.59%
ROIC/WACCN/A
Cap/Depr(3y)184.3%
Cap/Depr(5y)140.27%
Cap/Sales(3y)6.89%
Cap/Sales(5y)5.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.24%
EPS Next Y28.98%
EPS Next 2Y29.76%
EPS Next 3Y28%
EPS Next 5Y23.01%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%17.09%
Revenue Next Year14.51%
Revenue Next 2Y13.43%
Revenue Next 3Y13.35%
Revenue Next 5Y13.3%
EBIT growth 1Y2.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year242.67%
EBIT Next 3Y62.94%
EBIT Next 5Y43.2%
FCF growth 1Y117.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1396.48%
OCF growth 3YN/A
OCF growth 5YN/A